The intravenous infusion of ferric carboxymaltose in patients with chronic HF and iron deficiency led to improved health status and NYHA functional class, study results suggested. Researchers for the ...

Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price. Routine bloodwork from the spring 2018 visit suggested anemia, of which ...

Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research.

Pharmacosmos A/S, a Denmark-based industry leader for developing and marketing medicines for the treatment of iron deficiency, said its Monofer, a new generation of innovative intravenous iron for the ...

Receiving an iron infusion every one to two years could help people with heart failure avoid being admitted to hospital, new research suggests. Nearly one million people in the UK are living with ...

During a period of rapid fluctuation in the intravenous iron market, there was increased use of a more expensive drug that afforded providers additional revenue. Objectives: Medicare Part B payment ...

Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price. Routine bloodwork from that spring 2018 medical visit suggested ...

Gov. Larry Hogan recently announced a four-year, $72 million program to support maternal and child health with an emphasis on prevention and early intervention. “By investing in access to prenatal ...